Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models.

Long-term benzodiazepine and NSAID prescribing are associated with significantly increased costs and reduced QALYs. Targeting inappropriate NSAID prescribing appears to be the most cost-effective PIP intervention.